Product Information
PHENTERMINE 37.5 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.0814 per EA under NDC 11534015930. Its NADAC has been published 275 times since May 15, 2019.
Strength
37.5 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534015930
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/17/2024
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205017On Market Since
1/24/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG CAPSULE has been published 275 times since May 15, 2019, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0814 per EA |
|---|---|
| All-time high | $0.1421 (Apr 10, 2024) |
| All-time low | $0.0688 (Dec 23, 2020) |
| Median price | $0.1005 |
| Average price | $0.1017 |
| Largest weekly change | +64.3% (Nov 22, 2023) |
| Weeks tracked | 275 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.0814 per EA (NDC 11534015930), effective Aug 14, 2024.
How has the price of PHENTERMINE 37.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG CAPSULE has declined 27.7%. It has been tracked across 275 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG CAPSULE?
Since May 15, 2019, the NADAC for PHENTERMINE 37.5 MG CAPSULE has ranged from a low of $0.0688 (Dec 23, 2020) to a high of $0.1421 (Apr 10, 2024), with a median of $0.1005 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0708 per EA — about 13% below PHENTERMINE 37.5 MG CAPSULE.
Who manufactures PHENTERMINE 37.5 MG CAPSULE?
PHENTERMINE 37.5 MG CAPSULE (NDC 11534015930) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification